메뉴 건너뛰기




Volumn 92, Issue 7, 2014, Pages 546-550

Catching broken hearts: Pre-clinical detection of doxorubicin and trastuzumab mediated cardiac dysfunction in the breast cancer setting1

Author keywords

Cardiac magnetic resonance imaging; Cardio oncology; Doxorubicin; Transthoracic echocardiography; Trastuzumab

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; MONOCLONAL ANTIBODY; TRASTUZUMAB;

EID: 84903277061     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2013-0470     Document Type: Review
Times cited : (10)

References (60)
  • 1
    • 0018757883 scopus 로고
    • Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography
    • doi:10.1056/ NEJM197902083000603. PMID:759880
    • Alexander, J., Dainiak, N., Berger, H.J., Goldman, L., Johnstone, D., Reduto, L., et al. 1979. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. N. Engl. J. Med. 300(6): 278-283. doi:10.1056/ NEJM197902083000603. PMID:759880.
    • (1979) N. Engl. J. Med , vol.300 , Issue.6 , pp. 278-283
    • Alexander, J.1    Dainiak, N.2    Berger, H.J.3    Goldman, L.4    Johnstone, D.5    Reduto, L.6
  • 2
    • 4544302695 scopus 로고    scopus 로고
    • Anti-oxidants and apoptosis: Attenuation of doxorubicin induced cardiomyopathy by carvedilol
    • doi:10.1016/j.yjmcc.2004.07.001. PMID:15380672
    • Armstrong, S.C. 2004. Anti-oxidants and apoptosis: Attenuation of doxorubicin induced cardiomyopathy by carvedilol. J. Mol. Cell. Cardiol. 37(4): 817-821. doi:10.1016/j.yjmcc.2004.07.001. PMID:15380672.
    • (2004) J. Mol. Cell. Cardiol , vol.37 , Issue.4 , pp. 817-821
    • Armstrong, S.C.1
  • 3
    • 0018102512 scopus 로고
    • Anthracycline cardiomyopathy monitored by morphologic changes
    • PMID:667860
    • Billingham, M.E., Mason, J.W., Bristow, M.R., and Daniels, J.R. 1978. Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treat. Rep. 62(6): 865-872. PMID:667860.
    • (1978) Cancer Treat. Rep , vol.62 , Issue.6 , pp. 865-872
    • Billingham, M.E.1    Mason, J.W.2    Bristow, M.R.3    Daniels, J.R.4
  • 5
    • 33845402341 scopus 로고    scopus 로고
    • Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition
    • doi:10.1161/CIRCULATIONAHA.106.635144. PMID:17101852
    • Cardinale, D., Colombo, A., Sandri, M.T., Lamantia, G., Colombo, N., Civelli, M., et al. 2006. Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition. Circulation, 114(23): 2474-2481. doi:10.1161/CIRCULATIONAHA.106.635144. PMID:17101852.
    • (2006) Circulation , vol.114 , Issue.23 , pp. 2474-2481
    • Cardinale, D.1    Colombo, A.2    Sandri, M.T.3    Lamantia, G.4    Colombo, N.5    Civelli, M.6
  • 6
    • 0026610881 scopus 로고
    • Humanization of an anti-p185HER2 antibody for human cancer therapy
    • doi:10.1073/pnas.89.10. 4285. PMID:1350088
    • Carter, P., Presta, L., Gorman, C.M., Ridgway, J.B., Henner, D., Wong, W.L., et al. 1992. Humanization of an anti-p185HER2 antibody for human cancer therapy. Proc. Natl. Acad. Sci. U.S.A. 89(10): 4285-4289. doi:10.1073/pnas.89.10. 4285. PMID:1350088.
    • (1992) Proc. Natl. Acad. Sci. U.S.A , vol.89 , Issue.10 , pp. 4285-4289
    • Carter, P.1    Presta, L.2    Gorman, C.M.3    Ridgway, J.B.4    Henner, D.5    Wong, W.L.6
  • 7
    • 79955069468 scopus 로고    scopus 로고
    • Chemotherapy-induced cardiotoxicity: Role of the tissue Doppler in the early diagnosis of left ventricular dysfunction
    • doi:10.1097/CAD.0b013e3283443704. PMID:21301318
    • Di Lisi, D., Bonura, F., Macaione, F., Peritore, A., Meschisi, M., Cuttitta, F., et al. 2011. Chemotherapy-induced cardiotoxicity: role of the tissue Doppler in the early diagnosis of left ventricular dysfunction. Anticancer Drugs, 22(5):468-472. doi:10.1097/CAD.0b013e3283443704. PMID:21301318.
    • (2011) Anticancer Drugs , vol.22 , Issue.5 , pp. 468-472
    • Di, L.D.1    Bonura, F.2    Macaione, F.3    Peritore, A.4    Meschisi, M.5    Cuttitta, F.6
  • 8
    • 84874320403 scopus 로고    scopus 로고
    • Echocardiography and vascular ultrasound: New developments and future directions
    • doi:10.1016/j.cjca.2012.11.001. PMID:23333166
    • Ducas, R., Tsang, W., Chong, A.A., Jassal, D.S., Lang, R.M., Leong-Poi, H., and Chan, K.L. 2013. Echocardiography and vascular ultrasound: new developments and future directions. Can. J. Cardiol. 29(3): 304-316. doi:10.1016/j.cjca.2012.11.001. PMID:23333166.
    • (2013) Can. J. Cardiol , vol.29 , Issue.3 , pp. 304-316
    • Ducas, R.1    Tsang, W.2    Chong, A.A.3    Jassal, D.S.4    Lang, R.M.5    Leong-Poi, H.6    Chan, K.L.7
  • 9
    • 84856636292 scopus 로고    scopus 로고
    • Comparisons between different polychemotherapy regimens for early breast cancer: Meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
    • Early Breast Cancer Trialists' Collaborative Group (EBCTCG, doi:10.1016/S0140-6736(11)61625-5. PMID:22152853
    • Early Breast Cancer Trialists' Collaborative Group (EBCTCG); Peto, R., Davies, C., Godwin, J., Gray, R., Pan, H.C., Clarke, M., et al. 2012. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials. Lancet, 379(9814): 432-444. doi:10.1016/S0140-6736(11)61625-5. PMID:22152853.
    • (2012) Lancet , vol.379 , Issue.9814 , pp. 432-444
    • Peto, R.1    Davies, C.2    Godwin, J.3    Gray, R.4    Pan, H.C.5    Clarke, M.6
  • 10
    • 43849094005 scopus 로고    scopus 로고
    • Cardiotoxicity profile of trastuzumab
    • doi:10.2165/00002018-200831060-00002. PMID:18484781
    • Ewer, S.M., and Ewer, M.S. 2008. Cardiotoxicity profile of trastuzumab. Drug Saf. 31(6): 459-467. doi:10.2165/00002018-200831060-00002. PMID:18484781.
    • (2008) Drug Saf , vol.31 , Issue.6 , pp. 459-467
    • Ewer, S.M.1    Ewer, M.S.2
  • 11
    • 40949103615 scopus 로고    scopus 로고
    • Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy
    • doi:10.1186/1532- 429X-10-5. PMID:18272009
    • Fallah-Rad, N., Lytwyn, M., Fang, T., Kirkpatrick, I., and Jassal, D.S. 2008. Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy. J. Cardiovasc. Magn. Reson. 10: 5. doi:10.1186/1532- 429X-10-5. PMID:18272009.
    • (2008) J. Cardiovasc. Magn. Reson , vol.10 , pp. 5
    • Fallah-Rad, N.1    Lytwyn, M.2    Fang, T.3    Kirkpatrick, I.4    Jassal, D.S.5
  • 12
    • 79957576807 scopus 로고    scopus 로고
    • The utility of cardiac biomarkers, tissue velocity and strain imaging and cardiac MRI in predicting early left ventricular dysfunction in patients with HER-2 positive breast cancer treated with adjuvant trastuzumab therapy
    • doi:10.1016/j.jacc.2010.11.063. PMID: 21616287
    • Fallah-Rad, N., Walker, J.R., Wassef, A., Lytwyn, M., Bohonis, S., Fang, T., et al. 2011. The utility of cardiac biomarkers, tissue velocity and strain imaging and cardiac MRI in predicting early left ventricular dysfunction in patients with HER-2 positive breast cancer treated with adjuvant trastuzumab therapy. J. Am. Coll. Cardiol. 57(22): 2263-2270. doi:10.1016/j.jacc.2010.11.063. PMID: 21616287.
    • (2011) J. Am. Coll. Cardiol , vol.57 , Issue.22 , pp. 2263-2270
    • Fallah-Rad, N.1    Walker, J.R.2    Wassef, A.3    Lytwyn, M.4    Bohonis, S.5    Fang, T.6
  • 13
    • 0029964861 scopus 로고    scopus 로고
    • Review of tests for monitoring doxorubicin-induced cardiomyopathy
    • doi:10.1159/000227621. PMID:8960141
    • Ganz, W.I., Sridhar, K.S., Ganz, S.S., Gonzalez, R., Chakko, S., and Serafini, A. 1996. Review of tests for monitoring doxorubicin-induced cardiomyopathy. Oncology, 53(6): 461-470. doi:10.1159/000227621. PMID:8960141.
    • (1996) Oncology , vol.53 , Issue.6 , pp. 461-470
    • Ganz, W.I.1    Sridhar, K.S.2    Ganz, S.S.3    Gonzalez, R.4    Chakko, S.5    Serafini, A.6
  • 14
    • 2342591455 scopus 로고    scopus 로고
    • The discovery of receptor tyrosine kinases: Targets for cancer therapy
    • doi:10.1038/nrc1360
    • Gschwind, A., Fischer, O.M., and Ullrich, A. 2004. The discovery of receptor tyrosine kinases: targets for cancer therapy. Nat. Rev. Cancer, 4(5): 361-370. doi:10.1038/nrc1360.
    • (2004) Nat. Rev. Cancer , vol.4 , Issue.5 , pp. 361-370
    • Gschwind, A.1    Fischer, O.M.2    Ullrich, A.3
  • 15
    • 58149250715 scopus 로고    scopus 로고
    • Multicentric, randomized phase III trial of two different adjuvant chemotherapy regimens plus three versus twelve months of trastuzumab in patients with HER2-positive breast cancer (Short-HER Trial; NCT00629278)
    • doi:10.3816/CBC.2008.n.056. PMID:18952561
    • Guarneri, V., Frassoldati, A., Bruzzi, P., D'Amico, R., Belfiglio, M., Molino, A., et al. 2008. Multicentric, randomized phase III trial of two different adjuvant chemotherapy regimens plus three versus twelve months of trastuzumab in patients with HER2-positive breast cancer (Short-HER Trial; NCT00629278). Clin. Breast Cancer, 8(5): 453-456. doi:10.3816/CBC.2008.n.056. PMID:18952561.
    • (2008) Clin. Breast Cancer , vol.8 , Issue.5 , pp. 453-456
    • Guarneri, V.1    Frassoldati, A.2    Bruzzi, P.3    D'amico, R.4    Belfiglio, M.5    Molino, A.6
  • 16
    • 70349337359 scopus 로고    scopus 로고
    • Trastuzumabinduced cardiomyopathy: Not as benign as it looks? A retrospective study
    • doi:10.1016/j.cardfail.2009.04.011. PMID:19786263
    • Guglin, M., Hartlage, G., Reynolds, C., Chen, R., and Patel, V. 2009. Trastuzumabinduced cardiomyopathy: not as benign as it looks? A retrospective study. J. Card. Fail. 15(8): 651-657. doi:10.1016/j.cardfail.2009.04.011. PMID:19786263.
    • (2009) J. Card. Fail , vol.15 , Issue.8 , pp. 651-657
    • Guglin, M.1    Hartlage, G.2    Reynolds, C.3    Chen, R.4    Patel, V.5
  • 17
    • 0032915392 scopus 로고    scopus 로고
    • Epidermal growth factor receptors: Critical mediators of multiple receptor pathways
    • doi:10.1016/S0955-0674(99)80024-6. PMID:10209149
    • Hackel, P.O., Zwick, E., Prenzel, N., and Ullrich, A. 1999. Epidermal growth factor receptors: critical mediators of multiple receptor pathways. Curr. Opin. Cell Biol. 11(2): 184-189. doi:10.1016/S0955-0674(99)80024-6. PMID:10209149.
    • (1999) Curr. Opin. Cell Biol , vol.11 , Issue.2 , pp. 184-189
    • Hackel, P.O.1    Zwick, E.2    Prenzel, N.3    Ullrich, A.4
  • 18
    • 67650351539 scopus 로고    scopus 로고
    • Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab
    • doi:10.1016/j. ahj.2009.05.031. PMID:19619708
    • Hare, J.L., Brown, J.K., Leano, R., Jenkins, C., Woodward, N., and Marwick, T.H. 2009. Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab. Am. Heart J. 158(2): 294-301. doi:10.1016/j. ahj.2009.05.031. PMID:19619708.
    • (2009) Am. Heart J , vol.158 , Issue.2 , pp. 294-301
    • Hare, J.L.1    Brown, J.K.2    Leano, R.3    Jenkins, C.4    Woodward, N.5    Marwick, T.H.6
  • 19
    • 77951662997 scopus 로고    scopus 로고
    • Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: A speckle tracking echocardiographic study
    • doi: 10.1136/hrt.2009.173997. PMID:20424152
    • Ho, E., Brown, A., Barrett, P., Morgan, R.B., King, G., Kennedy, M.J., and Murphy, R.T. 2010. Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study. Heart, 96(9): 701-707. doi: 10.1136/hrt.2009.173997. PMID:20424152.
    • (2010) Heart , vol.96 , Issue.9 , pp. 701-707
    • Ho, E.1    Brown, A.2    Barrett, P.3    Morgan, R.B.4    King, G.5    Kennedy, M.J.6    Murphy, R.T.7
  • 20
    • 53449093684 scopus 로고    scopus 로고
    • Adjuvant trastuzumab therapy for HER2-positive breast cancer
    • doi:10.3816/CBC.2008.n.037. PMID: 18757259
    • Jahanzeb, M. 2008. Adjuvant trastuzumab therapy for HER2-positive breast cancer. Clin. Breast Cancer, 8(4):324-333. doi:10.3816/CBC.2008.n.037. PMID: 18757259.
    • (2008) Clin. Breast Cancer , vol.8 , Issue.4 , pp. 324-333
    • Jahanzeb, M.1
  • 21
    • 63249107117 scopus 로고    scopus 로고
    • Utility of tissue Doppler and strain rate imaging in the early detection of trastuzumab and anthracycline mediated cardiomyopathy
    • doi:10.1016/j.echo.2009.01.016. PMID:19269133
    • Jassal, D.S., Han, S.Y., Hans, C., Sharma, A., Fang, T., Ahmadie, R., et al. 2009. Utility of tissue Doppler and strain rate imaging in the early detection of trastuzumab and anthracycline mediated cardiomyopathy. J. Am. Soc. Echocardiogr. 22(4): 418-424. doi:10.1016/j.echo.2009.01.016. PMID:19269133.
    • (2009) J. Am. Soc. Echocardiogr , vol.22 , Issue.4 , pp. 418-424
    • Jassal, D.S.1    Han, S.Y.2    Hans, C.3    Sharma, A.4    Fang, T.5    Ahmadie, R.6
  • 22
    • 33344478381 scopus 로고    scopus 로고
    • Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer
    • FinHer Study Investigators doi:10.1056/NEJMoa053028. PMID:16495393
    • Joensuu, H., Kellokumpu-Lehtinen, P.L., Bono, P., Alanko, T., Kataja, V., Asola, R., et al.; FinHer Study Investigators. 2006. Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer. N. Engl. J. Med. 354(8): 809-820. doi:10.1056/NEJMoa053028. PMID:16495393.
    • (2006) N. Engl. J. Med , vol.354 , Issue.8 , pp. 809-820
    • Joensuu, H.1    Kellokumpu-Lehtinen, P.L.2    Bono, P.3    Alanko, T.4    Kataja, V.5    Asola, R.6
  • 23
    • 78650177327 scopus 로고    scopus 로고
    • Ionizing radiation exposure to patients admitted with acute myocardial infarction in the United States
    • doi:10.1161/CIRCULATIONAHA.110.973339. PMID:21060076
    • Kaul, P., Medvedev, S., Hohmann, S.F., Douglas, P.S., Peterson, E.D., and Patel, M.R. 2010. Ionizing radiation exposure to patients admitted with acute myocardial infarction in the United States. Circulation, 122(21): 2160-2169. doi:10.1161/CIRCULATIONAHA.110.973339. PMID:21060076.
    • (2010) Circulation , vol.122 , Issue.21 , pp. 2160-2169
    • Kaul, P.1    Medvedev, S.2    Hohmann, S.F.3    Douglas, P.S.4    Peterson, E.D.5    Patel, M.R.6
  • 24
    • 0034820943 scopus 로고    scopus 로고
    • Anthracycline-induced cardiomyopathy
    • doi:10.1016/S0093-7754(01)90193-9. PMID:11552224
    • Keefe, D.L. 2001. Anthracycline-induced cardiomyopathy. Semin. Oncol. 28(4 Suppl. 11): 2-7. doi:10.1016/S0093-7754(01)90193-9. PMID:11552224.
    • (2001) Semin. Oncol , vol.28 , Issue.4 SUPPL. 11 , pp. 2-7
    • Keefe, D.L.1
  • 25
    • 84860906122 scopus 로고    scopus 로고
    • Effects of multidisciplinary team working on breast cancer survival: Retrospective, comparative, interventional cohort study of 13 722 women
    • doi:10.1136/bmj.e2718. PMID:22539013
    • Kesson, E.M., Allardice, G.M., George, W.D., Burns, H.J.G., and Morrison, D.S. 2012. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ, 344: e2718. doi:10.1136/bmj.e2718. PMID:22539013.
    • (2012) BMJ , vol.344
    • Kesson, E.M.1    Allardice, G.M.2    George, W.D.3    Burns, H.J.G.4    Morrison, D.S.5
  • 26
    • 33750959891 scopus 로고    scopus 로고
    • Threedimensional echocardiography: The benefits of the additional dimension
    • doi:10.1016/j.jacc.2006.07.047. PMID:17112995
    • Lang, R.M., Mor-Avi, V., Sugeng, L., Nieman, P.S., and Sahn, D.J. 2006. Threedimensional echocardiography: the benefits of the additional dimension. J.Am.Coll. Cardiol. 48: 2053-2069. doi:10.1016/j.jacc.2006.07.047. PMID:17112995.
    • (2006) J. Am. Coll. Cardiol , vol.48 , pp. 2053-2069
    • Lang, R.M.1    Mor-Avi, V.2    Sugeng, L.3    Nieman, P.S.4    Sahn, D.J.5
  • 27
    • 84863723945 scopus 로고    scopus 로고
    • Echocardiography signs of early cardiac impairment in patients with breast cancer and trastuzumab therapy
    • doi:10.1007/s00392-011-0406-0. PMID:22249492
    • Lange, S.A., Ebner, B., Wess, A., Kögel, M., Gajda, M., Hitschold, T., and Jung, J. 2012. Echocardiography signs of early cardiac impairment in patients with breast cancer and trastuzumab therapy. Clin. Res. Cardiol. 101(6): 415-426. doi:10.1007/s00392-011-0406-0. PMID:22249492.
    • (2012) Clin. Res. Cardiol , vol.101 , Issue.6 , pp. 415-426
    • Lange, S.A.1    Ebner, B.2    Wess, A.3    Kögel, M.4    Gajda, M.5    Hitschold, T.6    Jung, J.7
  • 28
    • 0015849162 scopus 로고
    • A clinicopathologic analysis of adriamycin cardiotoxicity
    • doi:10.1002/1097- 0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2. PMID:4353012
    • Lefrak, E.A., Pitha, J., Rosenheim, S., and Gottlieb, J.A. 1973. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer,32(2): 302-314. doi:10.1002/1097- 0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2. PMID:4353012.
    • (1973) Cancer , vol.32 , Issue.2 , pp. 302-314
    • Lefrak, E.A.1    Pitha, J.2    Rosenheim, S.3    Gottlieb, J.A.4
  • 29
    • 58149265138 scopus 로고    scopus 로고
    • Carvedilol as a protector against the cardiotoxicity induced by anthracyclines (doxorubicin)
    • PMID:19178029
    • Machado, V., Cabral, A., Monteiro, P., Gonçalves, L., and Providência, L.A. 2008. Carvedilol as a protector against the cardiotoxicity induced by anthracyclines (doxorubicin). Rev. Port. Cardiol. 27(10): 1277-1296. PMID:19178029.
    • (2008) Rev. Port. Cardiol , vol.27 , Issue.10 , pp. 1277-1296
    • Machado, V.1    Cabral, A.2    Monteiro, P.3    Gonçalves, L.4    Providência, L.A.5
  • 30
    • 34347389664 scopus 로고    scopus 로고
    • Cardiotoxicity of trastuzumab in clinical practice
    • doi:10.1056/NEJMc070065. PMID:17611218
    • McArthur, H.L., and Chia, S. 2007. Cardiotoxicity of trastuzumab in clinical practice. N. Engl. J. Med. 357(1): 94-85. doi:10.1056/NEJMc070065. PMID:17611218.
    • (2007) N. Engl. J. Med , vol.357 , Issue.1 , pp. 85-94
    • McArthur, H.L.1    Chia, S.2
  • 32
    • 33748061258 scopus 로고    scopus 로고
    • Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury
    • doi:10.1093/eurheartj/ehl013. PMID:16717080
    • Neilan, T.G., Jassal, D.S., Perez-Sanz, T.M., Raher, M.J., Pradhan, A.D., Buys, E.S, et al. 2006. Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury. Eur. Heart J. 27(15): 1868-1875. doi:10.1093/eurheartj/ehl013. PMID:16717080.
    • (2006) Eur. Heart J , vol.27 , Issue.15 , pp. 1868-1875
    • Neilan, T.G.1    Jassal, D.S.2    Perez-Sanz, T.M.3    Raher, M.J.4    Pradhan, A.D.5    Buys, E.S.6
  • 33
    • 34248573600 scopus 로고    scopus 로고
    • Managing cardiotoxicity in anthracycline-treated breast cancers
    • doi:10.1517/14740338.6. 3.315. PMID:17480180
    • Ng, R., and Green, M.D. 2007. Managing cardiotoxicity in anthracycline-treated breast cancers. Expert Opin. Drug Saf. 6(3): 315-321. doi:10.1517/14740338.6. 3.315. PMID:17480180.
    • (2007) Expert Opin. Drug Saf , vol.6 , Issue.3 , pp. 315-321
    • Ng, R.1    Green, M.D.2
  • 34
    • 0035732998 scopus 로고    scopus 로고
    • Comparison of echocardiography and radionuclide ventriculography in the follow-up of left ventricular systolic function in adult lymphoma patients during doxorubicin therapy
    • doi:10.1046/j.1365-2796.2001.00820.x. PMID:11298849
    • Nousiainen, T., Vanninen, E., Jantunen, E., Puustinen, J., Remes, J., Rantala, A., and Hartikainen, J. 2001. Comparison of echocardiography and radionuclide ventriculography in the follow-up of left ventricular systolic function in adult lymphoma patients during doxorubicin therapy. J. Intern. Med. 249(4): 297-303. doi:10.1046/j.1365-2796.2001.00820.x. PMID:11298849.
    • (2001) J. Intern. Med , vol.249 , Issue.4 , pp. 297-303
    • Nousiainen, T.1    Vanninen, E.2    Jantunen, E.3    Puustinen, J.4    Remes, J.5    Rantala, A.6    Hartikainen, J.7
  • 35
    • 0034183463 scopus 로고    scopus 로고
    • New strategies for managing metastatic breast cancer
    • PMID:10853456
    • Olin, J.J., and Muss, H.B. 2000. New strategies for managing metastatic breast cancer. Oncology (Williston Park), 14: 629-641. PMID:10853456.
    • (2000) Oncology (Williston Park) , vol.14 , pp. 629-641
    • Olin, J.J.1    Muss, H.B.2
  • 36
    • 4644232608 scopus 로고    scopus 로고
    • Effect of Doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial
    • doi:10.1200/JCO.2004.03.516. PMID:15365066
    • Perez, E.A., Suman, V.J., Davidson, N.E., Kaufman, P.A., Martino, S., Dakhil, S.R., et al. 2004. Effect of Doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial. J. Clin. Oncol. 22(18): 3700-3704. doi:10.1200/JCO.2004.03.516. PMID:15365066.
    • (2004) J. Clin. Oncol , vol.22 , Issue.18 , pp. 3700-3704
    • Perez, E.A.1    Suman, V.J.2    Davidson, N.E.3    Kaufman, P.A.4    Martino, S.5    Dakhil, S.R.6
  • 37
    • 26844503270 scopus 로고    scopus 로고
    • Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
    • Herceptin Adjuvant (HERA) Trial Study Team doi:10.1056/NEJMoa052306. PMID:16236737
    • Piccart-Gebhart, M.J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., et al.; Herceptin Adjuvant (HERA) Trial Study Team. 2005. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N. Engl. J. Med. 353(16): 1659-1672. doi:10.1056/NEJMoa052306. PMID:16236737.
    • (2005) N. Engl. J. Med. , vol.353 , Issue.16 , pp. 1659-1672
    • Piccart-Gebhart, M.J.1    Procter, M.2    Leyland-Jones, B.3    Goldhirsch, A.4    Untch, M.5    Smith, I.6
  • 38
    • 79960691560 scopus 로고    scopus 로고
    • Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101-Breast): A randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trastuzumab-mediated left ventricular remodeling among patients with HER2+ early breast cancer using cardiac MRI
    • doi:10.1186/1471-2407-11-318. PMID: 21794114
    • Pituskin, E., Haykowsky, M., Mackey, J.R., Thompson, R.B., Ezekowitz, J., Koshman, S., et al. 2011. Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101-Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trastuzumab-mediated left ventricular remodeling among patients with HER2+ early breast cancer using cardiac MRI. BMC Cancer, 11: 318. doi:10.1186/1471-2407-11-318. PMID: 21794114.
    • (2011) BMC Cancer , vol.11 , pp. 318
    • Pituskin, E.1    Haykowsky, M.2    Mackey, J.R.3    Thompson, R.B.4    Ezekowitz, J.5    Koshman, S.6
  • 39
    • 50849096058 scopus 로고    scopus 로고
    • Anthracycline-trastuzumab regimens for HER2/neu-overexpressing breast cancer: Current experience and future strategies
    • doi:10.1093/annonc/mdn292. PMID:18480068
    • Rayson, D., Richel, D., Chia, S., Jackisch, C., van der Vegt, S., and Suter, T. 2008. Anthracycline-trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategies. Ann. Oncol. 19(9): 1530-1539. doi:10.1093/annonc/mdn292. PMID:18480068.
    • (2008) Ann. Oncol , vol.19 , Issue.9 , pp. 1530-1539
    • Rayson, D.1    Richel, D.2    Chia, S.3    Jackisch, C.4    van der Vegt, S.5    Suter, T.6
  • 40
    • 26844536978 scopus 로고    scopus 로고
    • Trastuzumab plus adjuvant chemotherapy for operable HER2- positive breast cancer
    • doi:10.1056/NEJMoa 052122. PMID:16236738
    • Romond, E.H., Perez, E.A., Bryant, J., Suman, V.J., Geyer, C.E., Jr., Davidson, N.E., et al. 2005. Trastuzumab plus adjuvant chemotherapy for operable HER2- positive breast cancer. N. Engl. J. Med. 353(16): 1673-1684. doi:10.1056/NEJMoa 052122. PMID:16236738.
    • (2005) N. Engl. J. Med , vol.353 , Issue.16 , pp. 1673-1684
    • Romond, E.H.1    Perez, E.A.2    Bryant, J.3    Suman, V.J.4    Geyer Jr., C.E.5    Davidson, N.E.6
  • 41
    • 79954593490 scopus 로고    scopus 로고
    • Early detection and prediction of cardiotoxicity in chemotherapy-treated patients
    • doi:10.1016/j.amjcard.2011.01.006. PMID: 21371685
    • Sawaya, H., Sebag, I.A., Plana, J.C., Januzzi, J.L., Ky, B., Cohen, V., et al. 2011. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am. J. Cardiol. 107(9): 1375-1380. doi:10.1016/j.amjcard.2011.01.006. PMID: 21371685.
    • (2011) Am. J. Cardiol , vol.107 , Issue.9 , pp. 1375-1380
    • Sawaya, H.1    Sebag, I.A.2    Plana, J.C.3    Januzzi, J.L.4    Ky, B.5    Cohen, V.6
  • 42
    • 0032563825 scopus 로고    scopus 로고
    • Doxorubicin-induced cardiomyopathy
    • doi:10.1056/NEJM199809243391307. PMID:9744975
    • Singal, P.K., and Iliskovic, N. 1998. Doxorubicin-induced cardiomyopathy. N. Engl. J. Med. 339(13): 900-905. doi:10.1056/NEJM199809243391307. PMID:9744975.
    • (1998) N. Engl. J. Med , vol.339 , Issue.13 , pp. 900-905
    • Singal, P.K.1    Iliskovic, N.2
  • 43
    • 0028275840 scopus 로고
    • Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats
    • doi:10.1161/01.CIR.89.6. 2829. PMID:8205698
    • Siveski-Iliskovic, N., Kaul, N., and Singal, P.K. 1994. Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats. Circulation, 89: 2829-2935. doi:10.1161/01.CIR.89.6. 2829. PMID:8205698.
    • (1994) Circulation , vol.89 , pp. 2829-2935
    • Siveski-Iliskovic, N.1    Kaul, N.2    Singal, P.K.3
  • 44
    • 0028888378 scopus 로고
    • Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect
    • doi:10.1161/01.CIR.91.1.10. PMID:7805190
    • Siveski-Iliskovic, N., Hill, M., Chow, D.A., and Singal, P.K. 1995. Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect. Circulation, 91: 10-15. doi:10.1161/01.CIR.91.1.10. PMID:7805190.
    • (1995) Circulation , vol.91 , pp. 10-15
    • Siveski-Iliskovic, N.1    Hill, M.2    Chow, D.A.3    Singal, P.K.4
  • 45
    • 37049183697 scopus 로고
    • Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
    • doi:10.1126/ science.3798106. PMID:3798106
    • Slamon, D.J., Clark, G.M., Wong, S.G., Levin, W.J., Ullrich, A., and McGuire, W.L. 1987. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235(4785): 177-182. doi:10.1126/ science.3798106. PMID:3798106.
    • (1987) Science , vol.235 , Issue.4785 , pp. 177-182
    • Slamon, D.J.1    Clark, G.M.2    Wong, S.G.3    Levin, W.J.4    Ullrich, A.5    McGuire, W.L.6
  • 46
    • 0035869407 scopus 로고    scopus 로고
    • Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
    • doi:10.1056/NEJM200103153441101. PMID:11248153
    • Slamon, D.J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., et al. 2001. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N. Engl. J. Med. 344(11): 783-792. doi:10.1056/NEJM200103153441101. PMID:11248153.
    • (2001) N. Engl. J. Med , vol.344 , Issue.11 , pp. 783-792
    • Slamon, D.J.1    Leyland-Jones, B.2    Shak, S.3    Fuchs, H.4    Paton, V.5    Bajamonde, A.6
  • 47
    • 33845914783 scopus 로고    scopus 로고
    • 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: A randomised controlled trial
    • HERA study team doi:10.1016/S0140-6736(07)60028-2. PMID:17208639
    • Smith, I., Procter, M., Gelber, R.D., Guillaume, S., Feyereislova, A., Dowsett, M., et al.; HERA study team. 2007. 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. Lancet, 369(9555): 29-36. doi:10.1016/S0140-6736(07)60028-2. PMID:17208639.
    • (2007) Lancet , vol.369 , Issue.9555 , pp. 29-36
    • Smith, I.1    Procter, M.2    Gelber, R.D.3    Guillaume, S.4    Feyereislova, A.5    Dowsett, M.6
  • 48
    • 0035108975 scopus 로고    scopus 로고
    • Measurement of left ventricular dimensions and function in patients with dilated cardiomyopathy
    • doi:10.1002/jmri.1052. PMID:11241808
    • Strohm, O., Schultz-Menger, J., Pilz, B., Osterziel, K.J., Dietz, R., and Friedrich, M.G. 2001. Measurement of left ventricular dimensions and function in patients with dilated cardiomyopathy. J. Magn. Reson. Imaging, 13(3): 367-371. doi:10.1002/jmri.1052. PMID:11241808.
    • (2001) J. Magn. Reson. Imaging , vol.13 , Issue.3 , pp. 367-371
    • Strohm, O.1    Schultz-Menger, J.2    Pilz, B.3    Osterziel, K.J.4    Dietz, R.5    Friedrich, M.G.6
  • 49
    • 34548531901 scopus 로고    scopus 로고
    • Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial
    • doi:10.1200/ JCO.2006.09.1611. PMID:17646669
    • Suter, T.M., Procter, M., van Veldhuisen, D.J., Muscholl, M., Bergh, J., Carlomagno, C., et al. 2007. Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial. J. Clin. Oncol. 25(25): 3859-3865. doi:10.1200/ JCO.2006.09.1611. PMID:17646669.
    • (2007) J. Clin. Oncol , vol.25 , Issue.25 , pp. 3859-3865
    • Suter, T.M.1    Procter, M.2    van Veldhuisen, D.J.3    Muscholl, M.4    Bergh, J.5    Carlomagno, C.6
  • 50
    • 84856439776 scopus 로고    scopus 로고
    • Trastuzumab adjuvant chemotherapy and cardiotoxicity in real-world women with breast cancer
    • Italian Cardio-Oncologic Network doi:10.1016/j.cardfail.2011.10.015. PMID:22300778
    • Tarantini, L., Cioffi, G., Gori, S., Tuccia, F., Boccardi, L., Bovelli, D., et al.; Italian Cardio-Oncologic Network. 2012. Trastuzumab adjuvant chemotherapy and cardiotoxicity in real-world women with breast cancer. J. Card. Fail. 18(2): 113-119. doi:10.1016/j.cardfail.2011.10.015. PMID:22300778.
    • (2012) J. Card. Fail , vol.18 , Issue.2 , pp. 113-119
    • Tarantini, L.1    Cioffi, G.2    Gori, S.3    Tuccia, F.4    Boccardi, L.5    Bovelli, D.6
  • 51
    • 84872033896 scopus 로고    scopus 로고
    • Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: Application to patients undergoing cancer chemotherapy
    • doi:10.1016/j.yjmcc.2013.02.006, 10.1016/j.jacc.2012.09.035. PMID: 23199515
    • Thavendiranathan, P., Grant, A.D., Negishi, T., Plana, J.C., Popović, Z.B., and Marwick, T.H. 2013. Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. J. Am. Coll. Cardiol. 61(1): 77-84. doi:10.1016/j.yjmcc.2013.02.006, 10.1016/j.jacc.2012.09.035. PMID: 23199515.
    • (2013) J. Am. Coll. Cardiol , vol.61 , Issue.1 , pp. 77-84
    • Thavendiranathan, P.1    Grant, A.D.2    Negishi, T.3    Plana, J.C.4    Popović, Z.B.5    Marwick, T.H.6
  • 52
    • 32144438170 scopus 로고    scopus 로고
    • Non-invasive monitoring of cardiac hemodynamic parameters in doxorubicin-treated patients: Comparison with echocardiography
    • PMID:16739356
    • Villani, F., Meazza, R., and Materazzo, C. 2006. Non-invasive monitoring of cardiac hemodynamic parameters in doxorubicin-treated patients: comparison with echocardiography. Anticancer Res. 26(1B): 797-801. PMID:16739356.
    • (2006) Anticancer Res , vol.26 , Issue.1 B , pp. 797-801
    • Villani, F.1    Meazza, R.2    Materazzo, C.3
  • 53
    • 0036467826 scopus 로고    scopus 로고
    • Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer
    • doi:10.1200/JCO.20.3.719. PMID:11821453
    • Vogel, C.L., Cobleigh, M.A., Tripathy, D., Gutheil, J.C., Harris, L.N., Fehrenbacher, L., et al. 2002. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J. Clin. Oncol. 20(3): 719-726. doi:10.1200/JCO.20.3.719. PMID:11821453.
    • (2002) J. Clin. Oncol , vol.20 , Issue.3 , pp. 719-726
    • Vogel, C.L.1    Cobleigh, M.A.2    Tripathy, D.3    Gutheil, J.C.4    Harris, L.N.5    Fehrenbacher, L.6
  • 54
    • 68949121146 scopus 로고    scopus 로고
    • Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: A retrospective study
    • doi:10.1007/s10549-008-0260-6. PMID:19082707
    • Wadhwa, D., Fallah-Rad, N., Grenier, D., Krahn, M., Fang, T., Ahmadie, R., et al. 2009. Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: a retrospective study. Breast Cancer Res. Treat. 117(2): 357-364. doi:10.1007/s10549-008-0260-6. PMID:19082707.
    • (2009) Breast Cancer Res. Treat , vol.117 , Issue.2 , pp. 357-364
    • Wadhwa, D.1    Fallah-Rad, N.2    Grenier, D.3    Krahn, M.4    Fang, T.5    Ahmadie, R.6
  • 55
    • 74549224505 scopus 로고    scopus 로고
    • The art of healing broken hearts in breast cancer patients: Trastuzumab and heart failure
    • PMID:20098570
    • Walker, J.R., Singal, P.K., and Jassal, D.S. 2009. The art of healing broken hearts in breast cancer patients: Trastuzumab and heart failure. Exp. Clin. Cardiol. 14(3): e62-e67. PMID:20098570.
    • (2009) Exp. Clin. Cardiol , vol.14 , Issue.3
    • Walker, J.R.1    Singal, P.K.2    Jassal, D.S.3
  • 56
    • 77955294878 scopus 로고    scopus 로고
    • Role of three-dimensional echocardiography in breast cancer: Comparison with two-dimensional echocardiography, multiple-gated acquisition scans, and cardiac magnetic resonance imaging
    • doi:10.1200/JCO.2009.26.7294. PMID:20530277
    • Walker, J., Bhullar, N., Fallah-Rad, N., Lytwyn, M., Golian, M., Fang, T., et al. 2010. Role of three-dimensional echocardiography in breast cancer: comparison with two-dimensional echocardiography, multiple-gated acquisition scans, and cardiac magnetic resonance imaging. J. Clin. Oncol. 28(21):3429-3436. doi:10.1200/JCO.2009.26.7294. PMID:20530277.
    • (2010) J. Clin. Oncol , vol.28 , Issue.21 , pp. 3429-3436
    • Walker, J.1    Bhullar, N.2    Fallah-Rad, N.3    Lytwyn, M.4    Golian, M.5    Fang, T.6
  • 57
    • 33745615786 scopus 로고    scopus 로고
    • Herceptin (trastuzumab): Adjuvant and neoadjuvant trials
    • PMID:16833172
    • Yaal-Hahoshen, N., and Safra, T. 2006. Herceptin (trastuzumab): adjuvant and neoadjuvant trials. Isr. Med. Assoc. J. 8(6): 416-421. PMID:16833172.
    • (2006) Isr. Med. Assoc. J , vol.8 , Issue.6 , pp. 416-421
    • Yaal-Hahoshen, N.1    Safra, T.2
  • 58
    • 0034638917 scopus 로고    scopus 로고
    • Overexpression of ErbB2 in cancer and ErbB2- targeting strategies
    • doi:10.1038/sj.onc.1203972. PMID:11156524
    • Yu, D., and Hung, M.C. 2000. Overexpression of ErbB2 in cancer and ErbB2- targeting strategies. Oncogene, 19(53): 6115-6121. doi:10.1038/sj.onc.1203972. PMID:11156524.
    • (2000) Oncogene , vol.19 , Issue.53 , pp. 6115-6121
    • Yu, D.1    Hung, M.C.2
  • 59
    • 34248214786 scopus 로고    scopus 로고
    • Tissue Doppler imaging: A new prognosticator for cardiovascular diseases
    • doi:10.1016/j.jacc.2007.01.078. PMID:17498573
    • Yu, C.M., Sanderson, J.E., Marwick, T.H., and Oh, J.K. 2007. Tissue Doppler imaging: a new prognosticator for cardiovascular diseases. J. Am. Coll. Cardiol. 49(19): 1903-1914. doi:10.1016/j.jacc.2007.01.078. PMID:17498573.
    • (2007) J. Am. Coll. Cardiol , vol.49 , Issue.19 , pp. 1903-1914
    • Yu, C.M.1    Sanderson, J.E.2    Marwick, T.H.3    Oh, J.K.4
  • 60
    • 80054886881 scopus 로고    scopus 로고
    • Trastuzumab-induced cardiac dysfunction: A 'dual-hit'
    • PMID: 22065936
    • Zeglinski, M., Ludke, A., Jassal, D.S., and Singal, P.K. 2011. Trastuzumab-induced cardiac dysfunction: A 'dual-hit'. Exp. Clin. Cardiol. 16(3): 70-74. PMID: 22065936.
    • (2011) Exp. Clin. Cardiol , vol.16 , Issue.3 , pp. 70-74
    • Zeglinski, M.1    Ludke, A.2    Jassal, D.S.3    Singal, P.K.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.